ArchiveThe U.S. Food and Drug Administration(FDA) approved 37 new drugs into the market in 2022, including 22 chemical small molecules and 15 biological products. According to the prescription information for professionals and the related literature as well as patent information, this review describes the descriptions, indications, mechanism of action, dosage form and strength, adverse reactions, and one synthetic route of the chemical small molecules, and brief information about biological products.
Phage display technology(PDT) is an efficient screening technology in vitro for specific peptides of disease targets. This technology not only can screen out disease-related biomarkers but also serve as a powerful tool for drug research and development. Nowadays, PDT applies widely in the diagnosis and treatment of diseases and drug research. This paper reviews the principle of PDT, and its application in disease diagnosis, treatment, and drug research and development. The existing shortcomings of PDT and its application prospects are discussed to provide references for further research of PDT in modern medicine.
As a sample pretreatment method, solid phase microextraction(SPME) technology is used to enrich trace analytes in samples. It has the characteristics of simple operation, high throughput, low consumption of organic solvents, and automation. The extraction, concentration and injection are integrated into one procedure by this technology, which greatly improves the extraction efficiency. Based on the introduction of SPME technology, this paper reviews the application of SPME in the field of pharmaceutical analysis in recent years, and briefly discusses its limitations and development prospects, which provides a reference for the detection of trace components in complex substrates.
Extracellular vesicles(EVs) are naturally secreted by almost all types of cells, including human cancer cells, under physiological and pathological conditions. In recent years, due to their inherent biocompatibility, high stability, low immunogenicity, and essential role in intercellular communication in the pathological process, they have attracted wide attention and are considered as promising drug delivery vectors. In addition, they could have potential of treating cancer and other diseases. Accurate detection of EVs in vivo is the first critical step in developing EVs therapy. Different markers and imaging methods have been developed to enable non-invasive tracers in vivo, such as optical imaging and radioisotope imaging, which can be used to investigate the biological distribution, migration, and targeting characteristics in vivo of EVs. In this paper, the biological functions of EVs are briefly introduced, and the different imaging techniques available for in vivo tracers are discussed to promote the study of the biological process of EVs in vivo and the application of EVs-based nanomedicines.
Drug nanoparticles are often used to improve the bioavailability of oral drug delivery. However, due to physiological barriers such as mucus layer, P-glycoprotein(P-gp) efflux, and tight junctions in the gastrointestinal tract, the improvement of bioavailability of oral drugs by nanoparticles is limited. Nanoparticles modified with functional materials have become a research hotspot for oral drug delivery strategies due to their functionality, modifiability, and diversity. This study briefly describes the factors that limit the bioavailability of drugs and focuses on the summary of functional nanomaterials that enhance drug bioavailability by improving drug physicochemical properties and overcoming biological barriers to provide references and literature support for the study of drug loading strategies for poorly soluble drugs.
At present, the clinical applications of over 70% of drug candidates are limited due to their poor solubility. Adding hydrotropes is one of the common methods to improve the solubility of poorly soluble drugs. Hydrotropes are nonflammable, easily accessible, eco-friendly, and rapidly recyclable, so the applications of hydrotropes in improving the solubility of poorly soluble drugs are more and more extensive. However, the solubilization mechanisms of many hydrotropes are still unclear, and exploration of solubilization mechanisms is one of the current research hotspots. This paper introduces the classifications of hydrotropes, and focuses on the mechanisms of hydrotropes, including the molecular self-assembly of hydrotropes, the complexation of hydrotropes with solute molecules, and water structure changes, in order to provide theoretical references for applying hydrotropes to improve the solubility of poorly soluble drugs.
The industrial synthetic process of (S)-3-hydroxytetrahydrofuran was improved. (S)-4-Chloro-1,3-butanediol(3) was obtained by reduction of the starting material, ethyl (S)-4-chloro-3-hydroxybutyrate(2), with sodium borohydride in ethanol. The reaction mixture was quenched, followed by evaporation of the solvent. Then, the system was directly heated to give the title compound by ring-closure in water. The continuous extraction was used in the work-up so that the extraction efficiency was improved. After the distillation in vacuum and purification, 1 was obtained in a yield of 76.2% with 99.8% of chemical purity and the ee value greater than 99.8%. The improved synthetic process was low-cost and safe, which was suitable for industrial production.
Hyaluronidase is capable of degrading hyaluronic acid(HA) and has essential applications in biological medicine and drug delivery. The hyaluronate lyase(HylP) from Streptococcus bacteriophage was heterologously expressed and characterized in order to explore hyaluronidase with high activity, high substrate specificity and high stability. The results showed that HylP consisted of 337 amino acids belonged to the polysaccharide lyase family 16(PL16). The recombinant HylP could be expressed as a soluble form in Escherichia coli(DE3) with purified yield of 30 mg/L. The optimal temperature of recombinant HylP was 40 ℃, and the optimal pH value was 6.0. The HylP was stable under the temperature of 35 ℃ and pH 6.0 - 7.0, and it could degrade HA specifically with an activity of 24 u/mg. Enzymatic kinetic analysis showed that Michealis constant(Km) and catalytic constant(kcat) of HylP towards HA were 0.13 mg/mL and 13.80 s–1, respectively. In conclusion, HylP was a mesophilic, highly specific and active lyase towards HA, which had a potential application in producing functional low molecular weight HA.
The biological metal-organic framework(MOF) Ti-MOF-79 with adenine as an organic ligand and Ti as a metal core was synthesized under hydrothermal conditions. Quercetin(1) was used as a drug model to investigate the drug loading and release performance of Ti-MOF-79. The material and the drug-loaded complexes were characterized through transmission electron microscopy(SEM), X-ray diffractometry(XRD), differential scanning calorimetry(DSC), X-ray photoelectron spectroscopy(XPS), infrared spectroscopy(IR), ultraviolet spectroscopy(UV) and cytotoxicity test, and the drug loading and cumulative release rates were calculated. The results showed that Ti-MOF-79 was a regular long cylindrical crystal with porous structure. The results of in vitro experiments showed that the complexes with drug loading of (28.83±8.35)% had a sustained-release profile and had no obvious cytotoxicity, which indicated that MOF could become a novel carrier material.
Redox-responsive amphiphilic polymer, polyethylene glycol-cystamine-indometacin(PCI), was synthesized by conjugation of polyethylene glycol and the nonsteroidal anti-inflammatory agent indomethacin with disulfide bonds. The self-assembled micelles were prepared from the polymers by ultrasonic method to load the model antineoplastic agent, doxorubicin. Then, the title co-loaded polymeric micelles were obtained. The observation of transmission electron microscopy(TEM) revealed that the micelles were spherical in shape, and the results of dynamic light scattering showed that the average particle size and polydispersity index were (202.0±7.7)nm and 0.260±0.012, respectively. The encapsulation efficiency and drug loading of doxorubicin in the micelles were (90.71±3.78)% and(18.82±0.52)%, respectively. The cumulative release of doxorubicin from the micelles reached 80% in phosphate buffer(PBS) with glutathione(GSH) within 24 h, while in PBS without GSH was only about 40%. It was attributed to the redox-sensitive characteristics of disulfide bonds. The results of cytotoxicity experiments showed that the naked carriers had a certain antitumor effect on human hepatoma cells(HepG2 cells), while the co-loaded micelles presented enhanced antitumor effect on HepG2 cells. However, compared with free doxorubicin, the cytotoxicity of co-loaded micelles was weaker after 24 h co-incubation with HepG2 cells. The results of uptake experiments revealed that the cellular uptake of micelles in HepG2 cells was time-dependent.
Based on the concept of Quality by Design, the quality target product profile(QTPP) and critical quality attributes(CQAs) of the self-made generic-retentive sustained-release tablets were defined with the marketed pregabalin sustained-release tablets as the reference listed drug. The amounts of a blend of polyvinyl acetate and povidone(Kollidon SR), polyoxyethylene, carbomer and crospovidone were optimized by single factor test combined with central composite design-response surface methodology with floating lag time, long floating duration and cumulative release rates at different sampling points(1, 4 and 24 h) as the dependent variables. By drawing the three-dimensional response surface plots, the optimized formulation parameters were obtained as follows: 19.25% of Kollidon SR, 15.50% of polyoxyethylene, 3.25% of carbomer, and 31.50% of crospovidone. The cumulative release rates at 1, 4 and 24 h of the optimized formulation were respectively 17.12%, 43.73% and 97.19% in the validation test, and the release behaviors between the self-made tablets and the resfecence listed drug were similar. The floating lag time was 30 s and long floating duration was over 10 h, indicating the floating characteristics of the self-made tablets met the design requirements.
Despite cascade impactors have similar design principles, different impactors do not always provide comparable data for the same product in some cases due to their diverse internal structures. This study aimed to investigate the cause of the differences in the results derived from the three different impactors testing a carrier-based dry powder inhaler(DPI) at different sampling inhalation volumes, and discuss the applicability of the three impactors in in vitro-in vivo correlation(IVIVC) studies. The formulation was prepared by mixing micronized chlorpheniramine maleate with coarse lactose carrier particles, and Breezhaler® was adopted as the inhalation device. The measurement was performed at the flow rate of 60 L/min using fast screening impactor(FSI), Andersen cascade impactor(ACI), and next generation impactor(NGI) at five sampling volumes of 0.5, 1, 2, 4 and 5 L, respectively. The results indicated that the minimum sampling volumes to ensure accurate delivery performance assessment of the DPI by FSI, ACI and NGI were 1, 2 and 2 L, respectively. However, when the sampling volumes were less than 2 L, the FSI provided more reliable results reflecting the real dispersive condition of the formulation delivered by Breezhaler®, while the ACI presented a relatively complete particle size distribution. When the sampling volumes were no less than 2 L, the fine particle dose(FPD) measured by the NGI was almost the same as that measured by the FSI. Nevertheless, a significant difference in FPD values was observed between the ACI and the other two impactors, which might relate to the considerable interstage losses in the ACI. This study might provide a reference for selecting and applying different impactors in the DPI in vitro evaluation and the possible IVIVC model establishment.
The equilibrium solubility, oil-water partition coefficient and permeability values of oseltamivir phosphate(2) and sofosbuvir(3) were determined. The equilibrium solubilities of 2 and 3 in buffer solutions of pH 1.2, pH 4.5 and pH 6.8 were determined by flask shaking method to judge the solubility properties of two drugs. The oil-water partition coefficients of 2 and 3 in octanol-buffer solutions with different pH values were measured. The permeabilities of 2 and 3 in pH 5.0, pH 6.5 and pH 7.4 buffer solutions were measured by parallel artificial membrane permeation assay(PAMPA). The results showed that 2 was a drug with high solubility and permeability characteristics, and the oil-water partition coefficient was greatly affected by the volume ratio of oil to water. And 3 was a drug with low solubility, high permeability and high lipid solubility characteristics. However, the solubility of methyldopa(1) could not be determined by the same method due to the problem of sample stability. In addition, this study described and analysed the possible problems and influencing factors in the research process, which provided the data to support the establishment of the WHO list of essential medicines.
In order to better control the qualities of sodium cromoglicate(1) and its eye drops, the related substances were determined by HPLC with reference to European pharmacopoeia(EP 10.0). The results showed that the total amount of related substances in eighteen batches of samples was 0.2% - 0.4%, and the impurity content of the samples increased in the oxidation environment. According to the 2020 edition of the Pharmacopoeia of the People’s Republic of China(ChP 2020), the solution color was visually inspected. The results showed that the color of 1 eye drops was inconsistent with the "colorless or almost colorless" described in the current pharmacopoeia. In addition, the molar concentration ratio of osmotic pressure of 1 eye drops was determined. The results showed that eight out of fifteen batches of samples could not meet the isotonic requirements, and the lowest value of the osmolality ratio was only 0.26. The properties, solution color, osmotic molar concentration and related substances were added and revised, which could control the product quality more effectively, and also provide a reference for the improvement of other drug standards and the formulation of pharmacopoeia standards.
The dissolution method of bedaquiline fumarate(1) tablets with good discrimination was established. By investigating the equilibrium solubility of 1 in various pH media, it was confirmed that 1 possesses a pH-dependent solubility in the physiological pH range. On this basis, with difference factor(f1) as the evaluation index, and the tablet disintegration property as the auxiliary index, the most discriminating dissolution method was selected by determining the dissolution curves of the self-developed preparations prepared with different particle sizes of 1 in each dissolution medium, that is, the basket method was adopted with pH 1.0 hydrochloric acid as the dissolution medium, the rotation speed was 100 r/min, and the medium volume was 900 mL. The established and optimized dissolution method can effectively distinguish the self-developed preparations with different quality attributes, which provides an effective reference for the development of this variety of generic drugs.
In this paper, spores of Geobacillus stearothermophilus were inoculated to different solutions, and their heat resistances(D values) were determined by the survivor curve method. The results indicated that D values of spores of Geobacillus stearothermophilus in purified water, trypticase soy broth(TSB) medium, 5% glucose injection, and sodium bicarbonate injection were 3.26, 3.61, 0.97, and 2.94 min, respectively. So, differences in heat resistance of spores in different solutions should be generally considered when selecting spores and biological indicators, and the inoculum size should be calculated by D values to get more accurate biological lethality in the biological qualification of sterilization validation, and keep enough safety margin for the thermal lethality in order to provide sufficient sterility assurance level in the sterilization process performance qualification of the parenteral drugs.
An ion chromatographic method was established for the simultaneous determination of trifluoroacetic acid(2) and acetic acid(3) in atosiban acetate(1) bulk drug and its injection. The Dionex IonPacTM AS23 anion column(4 mm×25 cm, 5 μm) was adopted, and the 1.0 mmol/L sodium bicarbonate solution and 4.0 mmol/L sodium carbonate solution were used as eluents. The flow rate was 1.0 mL/min, the column temperature was 30 ℃, and the injection volume was 25 μL. The results showed that it was linear for 2 and 3 in the ranges of 0.03 - 11.53 μg/mL and 0.01 - 0.20 mg/mL, respectively. The LOQs of 2 and 3 were 1.4 and 5.1 ng, and the LODs were 0.7 and 2.5 ng, respectively. The average recoveries(n=6) of 2 and 3 in 1 bulk drug were 100.9% and 101.8%, with the RSDs of 0.60% and 0.74%, respectively. The average recoveries(n=6) of 2 and 3 in 1 for injection were 100.4% and 101.5%, with the RSDs of 0.86% and 0.53%, respectively. The established method is accurate, sensitive and reproducible, which can provide a scientific basis for the dosage control of 2 in 1 and the simultaneous determination of 2 and 3 in 1.
An HPLC method for the simultaneous determination of twelve related substances(2 - 13) in rosuvastatin calcium(1) was established. The Welch C18 column(4.6 mm×250 mm, 5 µm) was used, and the analysis was carried out in the gradient elution mode, with a solvent mixture comprising of 1% trifluoroacetic acid in water, acetonitrile and water(1∶35∶65, volume ratio) as mobile phase A, and a solvent mixture comprising of 1% trifluoroacetic acid in water, acetonitrile and water(1∶90∶10, volume ratio) as mobile phase B. The detection wavelength was 242 nm, the flow rate was 1.0 mL/min, and the column temperature was 40 ℃. The results showed that the resolution between 1 and its related substances was greater than 1.5, and it was linear for 1 - 13 in the corresponding mass concentration ranges. The LODs of 1 - 13 were 0.028 95 - 0.060 21 µg/mL, and the LOQs were 0.096 50 -0.200 71 µg/mL. The average recoveries(n=9) of 2 - 13 were 94.59% - 102.00%, with the RSDs of 0.79% - 4.06%. The determination results of three batches of 1 bulk drug showed that the contents of all related substances were less than 0.1% and the total impurity content was less than 1.0%, except related substance 3, whose content was less than 0.2%. The established method has good resolution, high sensitivity and specificity, which is suitable for the determination of related substances in 1.